Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)

Inclusion Criteria: * Subject, and the parent/guardian of the subject, was to have demonstrated their willingness to participate in the study and comply with its procedures by signing a written Informed Consent. * Subject was to be 6-11 years of age, of either sex and of any race. * If female, subject was to be premenarcheal. * Subject was to be willing to avoid eating, drinking, gum chewing, and teeth brushing for one hour prior to enrollment. * Subject was to be free of any clinically significant disease that would interfere with study evaluations, including allergic rhinitis and respiratory infections. * Subject was to have understood and been able to adhere to the dosing and visit schedules. Exclusion Criteria: * If female, subject who was pregnant, intended to become pregnant during the study or nursing. * Subject had used any investigational product within 30 days prior to enrollment. * Subject had any of the following clinical conditions: history of any significant medical conditions (based on reporting by parent or guardian): e.g., diabetes, heart disease, liver disease, kidney disease, breathing problems, cough with excessive phlegm, or persistent or chronic cough. * Subject had a current medical condition that, in the opinion of the Investigator or designee, may interfere with the ability to discriminate taste (e.g., common cold, sinus infection, bronchial infection, allergic rhinitis, etc.). * Subject was participating in any other clinical study(ies). * Subject was part of the staff or a family member of the staff personnel directly involved with this study. * Subject was allergic to or has sensitivity to the study drug or its excipients. * Subject had a history of allergic reaction to prescription and/or OTC medications and/or food products. * Subject had used any antihistamines within 24 hours prior to tasting as outlined in Section 9.4.7. * Subject used sedatives, tranquilizers, or monoamine oxidase inhibitor drugs.